384 related articles for article (PubMed ID: 9291432)
21. The association of vascular proliferation with HPV status and epithelial PCNA positivity in cervical intraepithelial lesions.
Soini Y; Pöllänen R; Kemppainen S; Pääkkö P; Lehto VP
APMIS; 1996 Mar; 104(3):183-90. PubMed ID: 8611192
[TBL] [Abstract][Full Text] [Related]
22. p53 protein expression but not mdm-2 protein expression is associated with rapid tumor cell proliferation and prognosis in renal cell carcinoma.
Moch H; Sauter G; Gasser TC; Buchholz N; Bubendorf L; Richter J; Jiang F; Dellas A; Mihatsch MJ
Urol Res; 1997; 25 Suppl 1():S25-30. PubMed ID: 9079753
[TBL] [Abstract][Full Text] [Related]
23. Expression of Ki-67 and squamous intraepithelial lesions are related with HPV in endocervical adenocarcinoma.
Cambruzzi E; Zettler CG; Alexandre CO
Pathol Oncol Res; 2005; 11(2):114-20. PubMed ID: 15999157
[TBL] [Abstract][Full Text] [Related]
24. Utility of Ki-67 and p53 in distinguishing cervical intraepithelial neoplasia 3 from squamous cell carcinoma of the cervix.
Tan GC; Sharifah NA; Shiran MS; Salwati S; Hatta AZ; Paul-Ng HO
Asian Pac J Cancer Prev; 2008; 9(4):781-4. PubMed ID: 19256776
[TBL] [Abstract][Full Text] [Related]
25. Characterization of human papillomavirus infection, P53 and Ki-67 expression in cervix cancer of Mozambican women.
Carrilho C; Gouveia P; Cantel M; Alberto M; Buane L; David L
Pathol Res Pract; 2003; 199(5):303-11. PubMed ID: 12908520
[TBL] [Abstract][Full Text] [Related]
26. Analysis of proliferative activity using Ki-67 on cervical precancerous lesions and the relationship to p53 expression.
Dellas A; Schultheiss E; Oberholzer M; Torhorst J; Gudat F
Anticancer Res; 1996; 16(6B):3403-7. PubMed ID: 9042198
[TBL] [Abstract][Full Text] [Related]
27. Co-overexpression of p53 and bcl-2 proteins in HPV-induced squamous cell carcinoma of the uterine cervix.
Grace VM; Shalini JV; lekha TT; Devaraj SN; Devaraj H
Gynecol Oncol; 2003 Oct; 91(1):51-8. PubMed ID: 14529662
[TBL] [Abstract][Full Text] [Related]
28. The possible role of p53 and bcl-2 expression in cervical carcinomas and their premalignant lesions.
Dimitrakakis C; Kymionis G; Diakomanolis E; Papaspyrou I; Rodolakis A; Arzimanoglou I; Leandros E; Michalas S
Gynecol Oncol; 2000 Apr; 77(1):129-36. PubMed ID: 10739702
[TBL] [Abstract][Full Text] [Related]
29. Malignant mixed Müllerian tumors of the uterus: a clinicopathologic, DNA flow cytometric, p53, and mdm-2 analysis of 44 cases.
Blom R; Guerrieri C; Stâl O; Malmström H; Sullivan S; Simonsen E
Gynecol Oncol; 1998 Jan; 68(1):18-24. PubMed ID: 9454654
[TBL] [Abstract][Full Text] [Related]
30. Expression of p53, Ki-67, and CD31 in the vaginal margins of radical hysterectomy in patients with stage IB carcinoma of the cervix.
Silva-Filho AL; Traiman P; Triginelli SA; Reis FM; Pedrosa MS; Miranda D; Abreu ES; Macarenco RS; Cunha-Melo JR
Gynecol Oncol; 2004 Dec; 95(3):646-54. PubMed ID: 15581977
[TBL] [Abstract][Full Text] [Related]
31. Nuclear TK1 expression is an independent prognostic factor for survival in pre-malignant and malignant lesions of the cervix.
Chen G; He C; Li L; Lin A; Zheng X; He E; Skog S
BMC Cancer; 2013 May; 13():249. PubMed ID: 23693054
[TBL] [Abstract][Full Text] [Related]
32. p53 mutation and MDM2 amplification are rare even in human papillomavirus-negative cervical carcinomas.
Ikenberg H; Matthay K; Schmitt B; Bauknecht T; Kiechle-Schwarz M; Göppinger A; Pfleiderer A
Cancer; 1995 Jul; 76(1):57-66. PubMed ID: 8630877
[TBL] [Abstract][Full Text] [Related]
33. Relationship between human papillomavirus infection and overexpression of p53 protein in cervical carcinomas and lymph node metastases.
Cavuslu S; Goodlad J; Hobbs C; Connor AM; Raju KS; Best JM; Cason J
J Med Virol; 1997 Oct; 53(2):111-7. PubMed ID: 9334921
[TBL] [Abstract][Full Text] [Related]
34. Expression of cyclins, p53, and Ki-67 in cervical squamous cell carcinomas: overexpression of cyclin A is a poor prognostic factor in stage Ib and II disease.
Shiohara S; Shiozawa T; Miyamoto T; Feng YZ; Kashima H; Kurai M; Suzuki A; Konishi I
Virchows Arch; 2005 Jun; 446(6):626-33. PubMed ID: 15891905
[TBL] [Abstract][Full Text] [Related]
35. Leiomyosarcoma of the uterus: A clinicopathologic, DNA flow cytometric, p53, and mdm-2 analysis of 49 cases.
Blom R; Guerrieri C; Stâl O; Malmström H; Simonsen E
Gynecol Oncol; 1998 Jan; 68(1):54-61. PubMed ID: 9454661
[TBL] [Abstract][Full Text] [Related]
36. Studies on tumor proliferation using monoclonal antibody, Ki 67 and expression of p53 in cancer of the uterine cervix.
Bar JK; Harlozinska A; Markowska J; Nowak M
Eur J Gynaecol Oncol; 1996; 17(5):378-80. PubMed ID: 8933835
[TBL] [Abstract][Full Text] [Related]
37. Transition from in situ to invasive testicular germ cell neoplasia is associated with the loss of p21 and gain of mdm-2 expression.
Datta MW; Macri E; Signoretti S; Renshaw AA; Loda M
Mod Pathol; 2001 May; 14(5):437-42. PubMed ID: 11353054
[TBL] [Abstract][Full Text] [Related]
38. Predictive value of p53, mdm-2, p21, and mib-1 for chemotherapy response in advanced breast cancer.
Sjöström J; Blomqvist C; Heikkilä P; Boguslawski KV; Räisänen-Sokolowski A; Bengtsson NO; Mjaaland I; Malmström P; Ostenstadt B; Bergh J; Wist E; Valvere V; Saksela E
Clin Cancer Res; 2000 Aug; 6(8):3103-10. PubMed ID: 10955790
[TBL] [Abstract][Full Text] [Related]
39. p53 and bcl-2 proteins as prognostic markers in human papillomavirus-associated cervical lesions.
Kurvinen K; Syrjänen K; Syrjänen S
J Clin Oncol; 1996 Jul; 14(7):2120-30. PubMed ID: 8683245
[TBL] [Abstract][Full Text] [Related]
40. Prognostic value of p53 protein accumulation in cancer cell nuclei in adenocarcinoma of the uterine cervix.
Tsuda H; Jiko K; Tsugane S; Yajima M; Yamada T; Tanemura K; Tsunematsu R; Ohmi K; Sonoda T; Hirohashi S
Jpn J Cancer Res; 1995 Nov; 86(11):1049-53. PubMed ID: 8567395
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
